As a matter of basic economics, fewer doctors means less care and more expensive services.
On a platform rife with falsehoods, a cohort of health-care professionals has stepped in to correct them.
Omicron is pushing hospitals to their limit, but the medical system still has an ethical responsibility to all patients—no matter the choices they make.
Omicron is inundating a health-care system that was already buckling under the cumulative toll of every previous surge.
Hospitals are already strained, and many health-care workers have little left to give.
Vaccines are amazing, but people who become infected need effective treatments.
Medical professionals are used to being believed, but as patients, they found that their expertise didn’t matter.
About one in five health-care workers has left their job since the pandemic started. This is their story—and the story of those left behind.
New guidelines urge doctors to talk like social-justice ideologues. Whether patients understand them is beside the point.
Hospital staff say they're facing a violence crisis.
Female doctors have always dealt with appearance-related confusion and disrespect. That only got worse during the pandemic.
The drug, molnupiravir, is named after Thor’s hammer, Mjölnir. But its power depends on reaching the right people, in the right time frame.
Vanishingly few people have legitimate reasons to avoid COVID-19 vaccination. Some say their doctors told them not to get vaccinated anyway.
Many people with long COVID feel that science is failing them. Neglecting them could make the pandemic even worse.
I’m frustrated, but I can’t really blame her. Here’s why.
After the horrors that health-care workers have endured during the pandemic, many are struggling to sympathize with people who won’t protect themselves.
The misperception that paramedics are merely ambulance drivers is everyone’s problem.
The pandemic was a big social experiment that sent asthma attacks plummeting.
The law’s opponents have a good chance of winning their next showdown, though it won’t threaten the law as a whole.
Aduhelm, the first new Alzheimer’s drug in 18 years, may not work. But states and Medicare might pay billions of dollars for it anyway.